nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Vemurafenib—melanoma	0.321	0.498	CbGbCtD
Zoledronate—ABCC1—Dactinomycin—melanoma	0.213	0.331	CbGbCtD
Zoledronate—ABCC1—Docetaxel—melanoma	0.11	0.171	CbGbCtD
Zoledronate—GGPS1—hair follicle—melanoma	0.00993	0.185	CbGeAlD
Zoledronate—GGPS1—retina—melanoma	0.00491	0.0914	CbGeAlD
Zoledronate—FDPS—hair follicle—melanoma	0.00458	0.0852	CbGeAlD
Zoledronate—GGPS1—mammalian vulva—melanoma	0.00393	0.0732	CbGeAlD
Zoledronate—GGPS1—head—melanoma	0.00281	0.0524	CbGeAlD
Zoledronate—ABCC1—hair follicle—melanoma	0.00266	0.0495	CbGeAlD
Zoledronate—CA2—hair follicle—melanoma	0.00238	0.0442	CbGeAlD
Zoledronate—CA12—eye—melanoma	0.00231	0.043	CbGeAlD
Zoledronate—FDPS—eye—melanoma	0.00228	0.0425	CbGeAlD
Zoledronate—FDPS—skin of body—melanoma	0.00199	0.037	CbGeAlD
Zoledronate—GGPS1—lymph node—melanoma	0.00197	0.0367	CbGeAlD
Zoledronate—FDPS—mammalian vulva—melanoma	0.00181	0.0337	CbGeAlD
Zoledronate—CA2—neck—melanoma	0.00159	0.0297	CbGeAlD
Zoledronate—CA12—head—melanoma	0.00131	0.0244	CbGeAlD
Zoledronate—FDPS—head—melanoma	0.0013	0.0241	CbGeAlD
Zoledronate—CA2—eye—melanoma	0.00119	0.0221	CbGeAlD
Zoledronate—CA2—retina—melanoma	0.00118	0.0219	CbGeAlD
Zoledronate—ABCC1—mammalian vulva—melanoma	0.00105	0.0196	CbGeAlD
Zoledronate—CA2—skin of body—melanoma	0.00103	0.0192	CbGeAlD
Zoledronate—CA2—mammalian vulva—melanoma	0.000941	0.0175	CbGeAlD
Zoledronate—FDPS—lymph node—melanoma	0.000908	0.0169	CbGeAlD
Zoledronate—Risedronate—PTGS2—melanoma	0.000737	0.529	CrCbGaD
Zoledronate—CA2—head—melanoma	0.000673	0.0125	CbGeAlD
Zoledronate—Clodronate—PTGS2—melanoma	0.000656	0.471	CrCbGaD
Zoledronate—ABCC1—lymph node—melanoma	0.000527	0.00982	CbGeAlD
Zoledronate—CA2—lymph node—melanoma	0.000471	0.00877	CbGeAlD
Zoledronate—Leukopenia—Bleomycin—melanoma	0.000412	0.00179	CcSEcCtD
Zoledronate—Dizziness—Vemurafenib—melanoma	0.00041	0.00178	CcSEcCtD
Zoledronate—Alopecia—Carmustine—melanoma	0.000408	0.00177	CcSEcCtD
Zoledronate—Angiopathy—Temozolomide—melanoma	0.000405	0.00176	CcSEcCtD
Zoledronate—Mental disorder—Carmustine—melanoma	0.000404	0.00176	CcSEcCtD
Zoledronate—Immune system disorder—Temozolomide—melanoma	0.000403	0.00175	CcSEcCtD
Zoledronate—Mediastinal disorder—Temozolomide—melanoma	0.000402	0.00175	CcSEcCtD
Zoledronate—Erythema—Carmustine—melanoma	0.000402	0.00175	CcSEcCtD
Zoledronate—Malnutrition—Carmustine—melanoma	0.000402	0.00175	CcSEcCtD
Zoledronate—Cough—Bleomycin—melanoma	0.000402	0.00175	CcSEcCtD
Zoledronate—Chills—Temozolomide—melanoma	0.0004	0.00174	CcSEcCtD
Zoledronate—Dehydration—Docetaxel—melanoma	0.000399	0.00173	CcSEcCtD
Zoledronate—Ill-defined disorder—Dactinomycin—melanoma	0.000398	0.00173	CcSEcCtD
Zoledronate—Anaemia—Dactinomycin—melanoma	0.000397	0.00173	CcSEcCtD
Zoledronate—Vomiting—Vemurafenib—melanoma	0.000394	0.00171	CcSEcCtD
Zoledronate—Alopecia—Temozolomide—melanoma	0.000394	0.00171	CcSEcCtD
Zoledronate—Chest pain—Bleomycin—melanoma	0.000392	0.0017	CcSEcCtD
Zoledronate—Myalgia—Bleomycin—melanoma	0.000392	0.0017	CcSEcCtD
Zoledronate—Abdominal pain upper—Docetaxel—melanoma	0.000392	0.0017	CcSEcCtD
Zoledronate—Rash—Vemurafenib—melanoma	0.000391	0.0017	CcSEcCtD
Zoledronate—Mental disorder—Temozolomide—melanoma	0.000391	0.0017	CcSEcCtD
Zoledronate—Dermatitis—Vemurafenib—melanoma	0.000391	0.0017	CcSEcCtD
Zoledronate—Back pain—Carmustine—melanoma	0.000389	0.00169	CcSEcCtD
Zoledronate—Headache—Vemurafenib—melanoma	0.000389	0.00169	CcSEcCtD
Zoledronate—Erythema—Temozolomide—melanoma	0.000388	0.00169	CcSEcCtD
Zoledronate—Malnutrition—Temozolomide—melanoma	0.000388	0.00169	CcSEcCtD
Zoledronate—Discomfort—Bleomycin—melanoma	0.000387	0.00168	CcSEcCtD
Zoledronate—Malaise—Dactinomycin—melanoma	0.000387	0.00168	CcSEcCtD
Zoledronate—Cramp muscle—Docetaxel—melanoma	0.000386	0.00168	CcSEcCtD
Zoledronate—Leukopenia—Dactinomycin—melanoma	0.000384	0.00167	CcSEcCtD
Zoledronate—Nasopharyngitis—Docetaxel—melanoma	0.000383	0.00167	CcSEcCtD
Zoledronate—Dysgeusia—Temozolomide—melanoma	0.00038	0.00165	CcSEcCtD
Zoledronate—Confusional state—Bleomycin—melanoma	0.000379	0.00165	CcSEcCtD
Zoledronate—Vision blurred—Carmustine—melanoma	0.000379	0.00165	CcSEcCtD
Zoledronate—Tremor—Carmustine—melanoma	0.000377	0.00164	CcSEcCtD
Zoledronate—Oedema—Bleomycin—melanoma	0.000376	0.00163	CcSEcCtD
Zoledronate—Anaphylactic shock—Bleomycin—melanoma	0.000376	0.00163	CcSEcCtD
Zoledronate—Back pain—Temozolomide—melanoma	0.000376	0.00163	CcSEcCtD
Zoledronate—Infection—Bleomycin—melanoma	0.000373	0.00162	CcSEcCtD
Zoledronate—Anaemia—Carmustine—melanoma	0.000371	0.00162	CcSEcCtD
Zoledronate—Dysphagia—Docetaxel—melanoma	0.000371	0.00161	CcSEcCtD
Zoledronate—Agitation—Carmustine—melanoma	0.000369	0.00161	CcSEcCtD
Zoledronate—Nausea—Vemurafenib—melanoma	0.000368	0.0016	CcSEcCtD
Zoledronate—Thrombocytopenia—Bleomycin—melanoma	0.000368	0.0016	CcSEcCtD
Zoledronate—Vision blurred—Temozolomide—melanoma	0.000366	0.00159	CcSEcCtD
Zoledronate—Myalgia—Dactinomycin—melanoma	0.000366	0.00159	CcSEcCtD
Zoledronate—Bronchospasm—Docetaxel—melanoma	0.000365	0.00159	CcSEcCtD
Zoledronate—Tremor—Temozolomide—melanoma	0.000364	0.00158	CcSEcCtD
Zoledronate—Discomfort—Dactinomycin—melanoma	0.000361	0.00157	CcSEcCtD
Zoledronate—Ill-defined disorder—Temozolomide—melanoma	0.00036	0.00157	CcSEcCtD
Zoledronate—Leukopenia—Carmustine—melanoma	0.00036	0.00156	CcSEcCtD
Zoledronate—Anaemia—Temozolomide—melanoma	0.000359	0.00156	CcSEcCtD
Zoledronate—Anorexia—Bleomycin—melanoma	0.000358	0.00156	CcSEcCtD
Zoledronate—Agitation—Temozolomide—melanoma	0.000357	0.00155	CcSEcCtD
Zoledronate—Angioedema—Temozolomide—melanoma	0.000355	0.00154	CcSEcCtD
Zoledronate—Pancytopenia—Docetaxel—melanoma	0.000352	0.00153	CcSEcCtD
Zoledronate—Hypotension—Bleomycin—melanoma	0.000351	0.00153	CcSEcCtD
Zoledronate—Oedema—Dactinomycin—melanoma	0.00035	0.00152	CcSEcCtD
Zoledronate—Malaise—Temozolomide—melanoma	0.00035	0.00152	CcSEcCtD
Zoledronate—Vertigo—Temozolomide—melanoma	0.000349	0.00152	CcSEcCtD
Zoledronate—Convulsion—Carmustine—melanoma	0.000348	0.00151	CcSEcCtD
Zoledronate—Infection—Dactinomycin—melanoma	0.000348	0.00151	CcSEcCtD
Zoledronate—Leukopenia—Temozolomide—melanoma	0.000348	0.00151	CcSEcCtD
Zoledronate—Hypertension—Carmustine—melanoma	0.000347	0.00151	CcSEcCtD
Zoledronate—Neutropenia—Docetaxel—melanoma	0.000347	0.00151	CcSEcCtD
Zoledronate—Palpitations—Temozolomide—melanoma	0.000343	0.00149	CcSEcCtD
Zoledronate—Thrombocytopenia—Dactinomycin—melanoma	0.000343	0.00149	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000342	0.00149	CcSEcCtD
Zoledronate—Myalgia—Carmustine—melanoma	0.000342	0.00149	CcSEcCtD
Zoledronate—Chest pain—Carmustine—melanoma	0.000342	0.00149	CcSEcCtD
Zoledronate—Anxiety—Carmustine—melanoma	0.000341	0.00148	CcSEcCtD
Zoledronate—Cough—Temozolomide—melanoma	0.000339	0.00147	CcSEcCtD
Zoledronate—Paraesthesia—Bleomycin—melanoma	0.000337	0.00147	CcSEcCtD
Zoledronate—Weight increased—Docetaxel—melanoma	0.000337	0.00147	CcSEcCtD
Zoledronate—Convulsion—Temozolomide—melanoma	0.000336	0.00146	CcSEcCtD
Zoledronate—Weight decreased—Docetaxel—melanoma	0.000335	0.00146	CcSEcCtD
Zoledronate—Hypertension—Temozolomide—melanoma	0.000335	0.00146	CcSEcCtD
Zoledronate—Dyspnoea—Bleomycin—melanoma	0.000335	0.00146	CcSEcCtD
Zoledronate—Anorexia—Dactinomycin—melanoma	0.000334	0.00145	CcSEcCtD
Zoledronate—Confusional state—Carmustine—melanoma	0.000331	0.00144	CcSEcCtD
Zoledronate—Arthralgia—Temozolomide—melanoma	0.000331	0.00144	CcSEcCtD
Zoledronate—Myalgia—Temozolomide—melanoma	0.000331	0.00144	CcSEcCtD
Zoledronate—Infestation NOS—Docetaxel—melanoma	0.00033	0.00144	CcSEcCtD
Zoledronate—Infestation—Docetaxel—melanoma	0.00033	0.00144	CcSEcCtD
Zoledronate—Anxiety—Temozolomide—melanoma	0.000329	0.00143	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000328	0.00143	CcSEcCtD
Zoledronate—Oedema—Carmustine—melanoma	0.000328	0.00143	CcSEcCtD
Zoledronate—Discomfort—Temozolomide—melanoma	0.000327	0.00142	CcSEcCtD
Zoledronate—Decreased appetite—Bleomycin—melanoma	0.000327	0.00142	CcSEcCtD
Zoledronate—Infection—Carmustine—melanoma	0.000326	0.00142	CcSEcCtD
Zoledronate—Renal failure—Docetaxel—melanoma	0.000325	0.00141	CcSEcCtD
Zoledronate—Dry mouth—Temozolomide—melanoma	0.000323	0.00141	CcSEcCtD
Zoledronate—Stomatitis—Docetaxel—melanoma	0.000322	0.0014	CcSEcCtD
Zoledronate—Pain—Bleomycin—melanoma	0.000321	0.0014	CcSEcCtD
Zoledronate—Conjunctivitis—Docetaxel—melanoma	0.000321	0.0014	CcSEcCtD
Zoledronate—Thrombocytopenia—Carmustine—melanoma	0.000321	0.0014	CcSEcCtD
Zoledronate—Tachycardia—Carmustine—melanoma	0.00032	0.00139	CcSEcCtD
Zoledronate—Confusional state—Temozolomide—melanoma	0.00032	0.00139	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000319	0.00139	CcSEcCtD
Zoledronate—Anaphylactic shock—Temozolomide—melanoma	0.000317	0.00138	CcSEcCtD
Zoledronate—Oedema—Temozolomide—melanoma	0.000317	0.00138	CcSEcCtD
Zoledronate—Infection—Temozolomide—melanoma	0.000315	0.00137	CcSEcCtD
Zoledronate—Anorexia—Carmustine—melanoma	0.000313	0.00136	CcSEcCtD
Zoledronate—Nervous system disorder—Temozolomide—melanoma	0.000311	0.00135	CcSEcCtD
Zoledronate—Thrombocytopenia—Temozolomide—melanoma	0.00031	0.00135	CcSEcCtD
Zoledronate—Feeling abnormal—Bleomycin—melanoma	0.00031	0.00135	CcSEcCtD
Zoledronate—Agranulocytosis—Docetaxel—melanoma	0.000308	0.00134	CcSEcCtD
Zoledronate—Skin disorder—Temozolomide—melanoma	0.000308	0.00134	CcSEcCtD
Zoledronate—Hypotension—Carmustine—melanoma	0.000306	0.00133	CcSEcCtD
Zoledronate—Hyperhidrosis—Temozolomide—melanoma	0.000306	0.00133	CcSEcCtD
Zoledronate—Decreased appetite—Dactinomycin—melanoma	0.000305	0.00132	CcSEcCtD
Zoledronate—Fatigue—Dactinomycin—melanoma	0.000302	0.00131	CcSEcCtD
Zoledronate—Anorexia—Temozolomide—melanoma	0.000302	0.00131	CcSEcCtD
Zoledronate—Pain—Dactinomycin—melanoma	0.0003	0.0013	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Carmustine—melanoma	0.000299	0.0013	CcSEcCtD
Zoledronate—Urticaria—Bleomycin—melanoma	0.000298	0.0013	CcSEcCtD
Zoledronate—Body temperature increased—Bleomycin—melanoma	0.000297	0.00129	CcSEcCtD
Zoledronate—Insomnia—Carmustine—melanoma	0.000297	0.00129	CcSEcCtD
Zoledronate—Hypoaesthesia—Docetaxel—melanoma	0.000295	0.00128	CcSEcCtD
Zoledronate—Paraesthesia—Carmustine—melanoma	0.000295	0.00128	CcSEcCtD
Zoledronate—Urinary tract disorder—Docetaxel—melanoma	0.000293	0.00127	CcSEcCtD
Zoledronate—Dyspnoea—Carmustine—melanoma	0.000292	0.00127	CcSEcCtD
Zoledronate—Oedema peripheral—Docetaxel—melanoma	0.000292	0.00127	CcSEcCtD
Zoledronate—Somnolence—Carmustine—melanoma	0.000292	0.00127	CcSEcCtD
Zoledronate—Connective tissue disorder—Docetaxel—melanoma	0.000292	0.00127	CcSEcCtD
Zoledronate—Urethral disorder—Docetaxel—melanoma	0.000291	0.00126	CcSEcCtD
Zoledronate—Feeling abnormal—Dactinomycin—melanoma	0.000289	0.00126	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000289	0.00126	CcSEcCtD
Zoledronate—Insomnia—Temozolomide—melanoma	0.000287	0.00125	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dactinomycin—melanoma	0.000287	0.00125	CcSEcCtD
Zoledronate—Decreased appetite—Carmustine—melanoma	0.000285	0.00124	CcSEcCtD
Zoledronate—Paraesthesia—Temozolomide—melanoma	0.000285	0.00124	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Carmustine—melanoma	0.000283	0.00123	CcSEcCtD
Zoledronate—Dyspnoea—Temozolomide—melanoma	0.000283	0.00123	CcSEcCtD
Zoledronate—Somnolence—Temozolomide—melanoma	0.000282	0.00123	CcSEcCtD
Zoledronate—Pain—Carmustine—melanoma	0.00028	0.00122	CcSEcCtD
Zoledronate—Constipation—Carmustine—melanoma	0.00028	0.00122	CcSEcCtD
Zoledronate—Dyspepsia—Temozolomide—melanoma	0.000279	0.00121	CcSEcCtD
Zoledronate—Eye disorder—Docetaxel—melanoma	0.000277	0.00121	CcSEcCtD
Zoledronate—Abdominal pain—Dactinomycin—melanoma	0.000277	0.0012	CcSEcCtD
Zoledronate—Body temperature increased—Dactinomycin—melanoma	0.000277	0.0012	CcSEcCtD
Zoledronate—Hypersensitivity—Bleomycin—melanoma	0.000277	0.0012	CcSEcCtD
Zoledronate—Decreased appetite—Temozolomide—melanoma	0.000276	0.0012	CcSEcCtD
Zoledronate—Flushing—Docetaxel—melanoma	0.000275	0.0012	CcSEcCtD
Zoledronate—Cardiac disorder—Docetaxel—melanoma	0.000275	0.0012	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Temozolomide—melanoma	0.000274	0.00119	CcSEcCtD
Zoledronate—Fatigue—Temozolomide—melanoma	0.000273	0.00119	CcSEcCtD
Zoledronate—Pain—Temozolomide—melanoma	0.000271	0.00118	CcSEcCtD
Zoledronate—Constipation—Temozolomide—melanoma	0.000271	0.00118	CcSEcCtD
Zoledronate—Feeling abnormal—Carmustine—melanoma	0.00027	0.00118	CcSEcCtD
Zoledronate—Asthenia—Bleomycin—melanoma	0.00027	0.00117	CcSEcCtD
Zoledronate—Angiopathy—Docetaxel—melanoma	0.000269	0.00117	CcSEcCtD
Zoledronate—Gastrointestinal pain—Carmustine—melanoma	0.000268	0.00117	CcSEcCtD
Zoledronate—Immune system disorder—Docetaxel—melanoma	0.000268	0.00117	CcSEcCtD
Zoledronate—Mediastinal disorder—Docetaxel—melanoma	0.000267	0.00116	CcSEcCtD
Zoledronate—Chills—Docetaxel—melanoma	0.000266	0.00116	CcSEcCtD
Zoledronate—Pruritus—Bleomycin—melanoma	0.000266	0.00116	CcSEcCtD
Zoledronate—Arrhythmia—Docetaxel—melanoma	0.000265	0.00115	CcSEcCtD
Zoledronate—Alopecia—Docetaxel—melanoma	0.000262	0.00114	CcSEcCtD
Zoledronate—Feeling abnormal—Temozolomide—melanoma	0.000261	0.00114	CcSEcCtD
Zoledronate—Mental disorder—Docetaxel—melanoma	0.00026	0.00113	CcSEcCtD
Zoledronate—Abdominal pain—Carmustine—melanoma	0.000259	0.00113	CcSEcCtD
Zoledronate—Body temperature increased—Carmustine—melanoma	0.000259	0.00113	CcSEcCtD
Zoledronate—Gastrointestinal pain—Temozolomide—melanoma	0.000259	0.00113	CcSEcCtD
Zoledronate—Malnutrition—Docetaxel—melanoma	0.000258	0.00112	CcSEcCtD
Zoledronate—Erythema—Docetaxel—melanoma	0.000258	0.00112	CcSEcCtD
Zoledronate—Hypersensitivity—Dactinomycin—melanoma	0.000258	0.00112	CcSEcCtD
Zoledronate—Dysgeusia—Docetaxel—melanoma	0.000253	0.0011	CcSEcCtD
Zoledronate—Urticaria—Temozolomide—melanoma	0.000252	0.00109	CcSEcCtD
Zoledronate—Asthenia—Dactinomycin—melanoma	0.000251	0.00109	CcSEcCtD
Zoledronate—Abdominal pain—Temozolomide—melanoma	0.000251	0.00109	CcSEcCtD
Zoledronate—Body temperature increased—Temozolomide—melanoma	0.000251	0.00109	CcSEcCtD
Zoledronate—Back pain—Docetaxel—melanoma	0.00025	0.00109	CcSEcCtD
Zoledronate—Muscle spasms—Docetaxel—melanoma	0.000248	0.00108	CcSEcCtD
Zoledronate—Hypersensitivity—Carmustine—melanoma	0.000242	0.00105	CcSEcCtD
Zoledronate—Diarrhoea—Dactinomycin—melanoma	0.00024	0.00104	CcSEcCtD
Zoledronate—Vomiting—Bleomycin—melanoma	0.000239	0.00104	CcSEcCtD
Zoledronate—Anaemia—Docetaxel—melanoma	0.000239	0.00104	CcSEcCtD
Zoledronate—Rash—Bleomycin—melanoma	0.000237	0.00103	CcSEcCtD
Zoledronate—Dermatitis—Bleomycin—melanoma	0.000237	0.00103	CcSEcCtD
Zoledronate—Asthenia—Carmustine—melanoma	0.000235	0.00102	CcSEcCtD
Zoledronate—Hypersensitivity—Temozolomide—melanoma	0.000234	0.00102	CcSEcCtD
Zoledronate—Syncope—Docetaxel—melanoma	0.000232	0.00101	CcSEcCtD
Zoledronate—Leukopenia—Docetaxel—melanoma	0.000231	0.00101	CcSEcCtD
Zoledronate—Palpitations—Docetaxel—melanoma	0.000228	0.000992	CcSEcCtD
Zoledronate—Asthenia—Temozolomide—melanoma	0.000227	0.000989	CcSEcCtD
Zoledronate—Loss of consciousness—Docetaxel—melanoma	0.000227	0.000987	CcSEcCtD
Zoledronate—Cough—Docetaxel—melanoma	0.000225	0.00098	CcSEcCtD
Zoledronate—Diarrhoea—Carmustine—melanoma	0.000224	0.000976	CcSEcCtD
Zoledronate—Pruritus—Temozolomide—melanoma	0.000224	0.000975	CcSEcCtD
Zoledronate—Convulsion—Docetaxel—melanoma	0.000224	0.000973	CcSEcCtD
Zoledronate—Nausea—Bleomycin—melanoma	0.000223	0.00097	CcSEcCtD
Zoledronate—Hypertension—Docetaxel—melanoma	0.000223	0.00097	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—melanoma	0.000223	0.000969	CcSEcCtD
Zoledronate—Rash—Dactinomycin—melanoma	0.000221	0.000961	CcSEcCtD
Zoledronate—Chest pain—Docetaxel—melanoma	0.00022	0.000956	CcSEcCtD
Zoledronate—Arthralgia—Docetaxel—melanoma	0.00022	0.000956	CcSEcCtD
Zoledronate—Myalgia—Docetaxel—melanoma	0.00022	0.000956	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000218	0.00095	CcSEcCtD
Zoledronate—Dizziness—Carmustine—melanoma	0.000217	0.000943	CcSEcCtD
Zoledronate—Diarrhoea—Temozolomide—melanoma	0.000217	0.000943	CcSEcCtD
Zoledronate—Dry mouth—Docetaxel—melanoma	0.000215	0.000935	CcSEcCtD
Zoledronate—Confusional state—Docetaxel—melanoma	0.000213	0.000924	CcSEcCtD
Zoledronate—Oedema—Docetaxel—melanoma	0.000211	0.000917	CcSEcCtD
Zoledronate—Anaphylactic shock—Docetaxel—melanoma	0.000211	0.000917	CcSEcCtD
Zoledronate—Dizziness—Temozolomide—melanoma	0.00021	0.000911	CcSEcCtD
Zoledronate—Infection—Docetaxel—melanoma	0.000209	0.000911	CcSEcCtD
Zoledronate—Vomiting—Carmustine—melanoma	0.000209	0.000907	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—melanoma	0.000208	0.000905	CcSEcCtD
Zoledronate—Shock—Docetaxel—melanoma	0.000207	0.000902	CcSEcCtD
Zoledronate—Rash—Carmustine—melanoma	0.000207	0.000899	CcSEcCtD
Zoledronate—Nervous system disorder—Docetaxel—melanoma	0.000207	0.000899	CcSEcCtD
Zoledronate—Dermatitis—Carmustine—melanoma	0.000207	0.000898	CcSEcCtD
Zoledronate—Thrombocytopenia—Docetaxel—melanoma	0.000206	0.000897	CcSEcCtD
Zoledronate—Tachycardia—Docetaxel—melanoma	0.000206	0.000895	CcSEcCtD
Zoledronate—Headache—Carmustine—melanoma	0.000205	0.000893	CcSEcCtD
Zoledronate—Skin disorder—Docetaxel—melanoma	0.000205	0.00089	CcSEcCtD
Zoledronate—Vomiting—Temozolomide—melanoma	0.000202	0.000876	CcSEcCtD
Zoledronate—Anorexia—Docetaxel—melanoma	0.000201	0.000874	CcSEcCtD
Zoledronate—Rash—Temozolomide—melanoma	0.0002	0.000869	CcSEcCtD
Zoledronate—Dermatitis—Temozolomide—melanoma	0.0002	0.000868	CcSEcCtD
Zoledronate—Headache—Temozolomide—melanoma	0.000199	0.000863	CcSEcCtD
Zoledronate—Hypotension—Docetaxel—melanoma	0.000197	0.000856	CcSEcCtD
Zoledronate—Nausea—Carmustine—melanoma	0.000195	0.000847	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000192	0.000835	CcSEcCtD
Zoledronate—Insomnia—Docetaxel—melanoma	0.000191	0.000829	CcSEcCtD
Zoledronate—Paraesthesia—Docetaxel—melanoma	0.000189	0.000823	CcSEcCtD
Zoledronate—Nausea—Temozolomide—melanoma	0.000188	0.000819	CcSEcCtD
Zoledronate—Dyspnoea—Docetaxel—melanoma	0.000188	0.000817	CcSEcCtD
Zoledronate—Somnolence—Docetaxel—melanoma	0.000187	0.000815	CcSEcCtD
Zoledronate—Dyspepsia—Docetaxel—melanoma	0.000186	0.000807	CcSEcCtD
Zoledronate—Decreased appetite—Docetaxel—melanoma	0.000183	0.000797	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Docetaxel—melanoma	0.000182	0.000791	CcSEcCtD
Zoledronate—Fatigue—Docetaxel—melanoma	0.000182	0.00079	CcSEcCtD
Zoledronate—Constipation—Docetaxel—melanoma	0.00018	0.000784	CcSEcCtD
Zoledronate—Pain—Docetaxel—melanoma	0.00018	0.000784	CcSEcCtD
Zoledronate—Feeling abnormal—Docetaxel—melanoma	0.000174	0.000755	CcSEcCtD
Zoledronate—Gastrointestinal pain—Docetaxel—melanoma	0.000172	0.000749	CcSEcCtD
Zoledronate—Abdominal pain—Docetaxel—melanoma	0.000167	0.000725	CcSEcCtD
Zoledronate—Body temperature increased—Docetaxel—melanoma	0.000167	0.000725	CcSEcCtD
Zoledronate—Hypersensitivity—Docetaxel—melanoma	0.000155	0.000675	CcSEcCtD
Zoledronate—Asthenia—Docetaxel—melanoma	0.000151	0.000658	CcSEcCtD
Zoledronate—Pruritus—Docetaxel—melanoma	0.000149	0.000648	CcSEcCtD
Zoledronate—Diarrhoea—Docetaxel—melanoma	0.000144	0.000627	CcSEcCtD
Zoledronate—Dizziness—Docetaxel—melanoma	0.000139	0.000606	CcSEcCtD
Zoledronate—Vomiting—Docetaxel—melanoma	0.000134	0.000583	CcSEcCtD
Zoledronate—Rash—Docetaxel—melanoma	0.000133	0.000578	CcSEcCtD
Zoledronate—Dermatitis—Docetaxel—melanoma	0.000133	0.000577	CcSEcCtD
Zoledronate—Headache—Docetaxel—melanoma	0.000132	0.000574	CcSEcCtD
Zoledronate—CA12—Metabolism—LUM—melanoma	0.000131	0.00183	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PHGDH—melanoma	0.000131	0.00183	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CUBN—melanoma	0.000131	0.00183	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HPSE—melanoma	0.000128	0.0018	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ABCB1—melanoma	0.000128	0.00179	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CSPG4—melanoma	0.000126	0.00177	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—BSG—melanoma	0.000126	0.00177	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SDHD—melanoma	0.000126	0.00177	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CUBN—melanoma	0.000126	0.00176	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000125	0.00176	CbGpPWpGaD
Zoledronate—Nausea—Docetaxel—melanoma	0.000125	0.000544	CcSEcCtD
Zoledronate—CA2—Metabolism—PLCB4—melanoma	0.000123	0.00172	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPAM—melanoma	0.000122	0.00171	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SDHD—melanoma	0.000122	0.0017	CbGpPWpGaD
Zoledronate—CA12—Metabolism—BSG—melanoma	0.000122	0.0017	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CSPG4—melanoma	0.000122	0.0017	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000119	0.00167	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PLA2G6—melanoma	0.000119	0.00166	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPAM—melanoma	0.000118	0.00165	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PRKCA—melanoma	0.000118	0.00165	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ERCC2—melanoma	0.000117	0.00163	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC6A11—melanoma	0.000115	0.00162	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIP4K2A—melanoma	0.000115	0.00162	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTAP—melanoma	0.000112	0.00157	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYO7A—melanoma	0.00011	0.00154	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—melanoma	0.000107	0.00151	CbGpPWpGaD
Zoledronate—CA14—Metabolism—VCAN—melanoma	0.000107	0.0015	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000105	0.00147	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PLA2G6—melanoma	0.000104	0.00145	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PLA2G6—melanoma	0.0001	0.0014	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LUM—melanoma	0.0001	0.0014	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PHGDH—melanoma	0.0001	0.0014	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HPSE—melanoma	9.81e-05	0.00137	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPAM—melanoma	9.79e-05	0.00137	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.66e-05	0.00135	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CUBN—melanoma	9.63e-05	0.00135	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HS3ST5—melanoma	9.36e-05	0.00131	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—VCAN—melanoma	9.33e-05	0.00131	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SDHD—melanoma	9.3e-05	0.0013	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CSPG4—melanoma	9.3e-05	0.0013	CbGpPWpGaD
Zoledronate—CA2—Metabolism—BSG—melanoma	9.3e-05	0.0013	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACER3—melanoma	9.22e-05	0.00129	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CG—melanoma	9.21e-05	0.00129	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP17A1—melanoma	9e-05	0.00126	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPAM—melanoma	9e-05	0.00126	CbGpPWpGaD
Zoledronate—CA12—Metabolism—VCAN—melanoma	8.99e-05	0.00126	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PPARG—melanoma	8.89e-05	0.00125	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.83e-05	0.00124	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.52e-05	0.00119	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GNA11—melanoma	8.5e-05	0.00119	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UGT2B10—melanoma	8.43e-05	0.00118	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	8.32e-05	0.00117	CbGpPWpGaD
Zoledronate—CA14—Metabolism—FASN—melanoma	8.32e-05	0.00117	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SLC5A5—melanoma	8.18e-05	0.00115	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CD—melanoma	8.1e-05	0.00113	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ALB—melanoma	7.99e-05	0.00112	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GNAQ—melanoma	7.9e-05	0.00111	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CD44—melanoma	7.9e-05	0.00111	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP17A1—melanoma	7.87e-05	0.0011	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HS3ST5—melanoma	7.84e-05	0.0011	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.76e-05	0.00109	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ALB—melanoma	7.66e-05	0.00107	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLA2G6—melanoma	7.66e-05	0.00107	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP17A1—melanoma	7.59e-05	0.00106	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP1B1—melanoma	7.58e-05	0.00106	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GNA11—melanoma	7.43e-05	0.00104	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—FASN—melanoma	7.27e-05	0.00102	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GNA11—melanoma	7.17e-05	0.001	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SLC5A5—melanoma	7.15e-05	0.001	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CB—melanoma	7.06e-05	0.000989	CbGpPWpGaD
Zoledronate—CA12—Metabolism—FASN—melanoma	7.01e-05	0.000983	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS2—melanoma	6.99e-05	0.00098	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GNAQ—melanoma	6.91e-05	0.000968	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CD44—melanoma	6.91e-05	0.000968	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC5A5—melanoma	6.9e-05	0.000967	CbGpPWpGaD
Zoledronate—CA2—Metabolism—VCAN—melanoma	6.88e-05	0.000963	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.77e-05	0.000948	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.7e-05	0.000939	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CUL3—melanoma	6.67e-05	0.000934	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TRRAP—melanoma	6.67e-05	0.000934	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GNAQ—melanoma	6.66e-05	0.000933	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CD44—melanoma	6.66e-05	0.000933	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP1B1—melanoma	6.62e-05	0.000928	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKR1B10—melanoma	6.49e-05	0.000909	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1B1—melanoma	6.39e-05	0.000895	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6.31e-05	0.000884	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ABCB1—melanoma	6.24e-05	0.000874	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTEN—melanoma	6.1e-05	0.000855	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLCB4—melanoma	5.94e-05	0.000832	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.85e-05	0.000819	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—FASN—melanoma	5.83e-05	0.000817	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP17A1—melanoma	5.8e-05	0.000813	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LUM—melanoma	5.78e-05	0.00081	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PRKCA—melanoma	5.74e-05	0.000805	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ERCC2—melanoma	5.7e-05	0.000798	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HPSE—melanoma	5.67e-05	0.000794	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC6A11—melanoma	5.58e-05	0.000782	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIP4K2A—melanoma	5.58e-05	0.000782	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CUBN—melanoma	5.56e-05	0.00078	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNA11—melanoma	5.48e-05	0.000768	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCB1—melanoma	5.46e-05	0.000764	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.45e-05	0.000764	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTAP—melanoma	5.43e-05	0.000761	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CSPG4—melanoma	5.37e-05	0.000753	CbGpPWpGaD
Zoledronate—CA2—Metabolism—FASN—melanoma	5.36e-05	0.000751	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.31e-05	0.000744	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS3—melanoma	5.29e-05	0.000741	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC5A5—melanoma	5.27e-05	0.000739	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCB1—melanoma	5.26e-05	0.000737	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SKI—melanoma	5.2e-05	0.000729	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNAQ—melanoma	5.09e-05	0.000714	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CD44—melanoma	5.09e-05	0.000714	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PRKCA—melanoma	5.02e-05	0.000703	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ERCC2—melanoma	4.98e-05	0.000698	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1B1—melanoma	4.88e-05	0.000684	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PHGDH—melanoma	4.84e-05	0.000678	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LUM—melanoma	4.84e-05	0.000678	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PRKCA—melanoma	4.84e-05	0.000678	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ERCC2—melanoma	4.8e-05	0.000673	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HPSE—melanoma	4.75e-05	0.000665	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CUBN—melanoma	4.66e-05	0.000653	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SDHD—melanoma	4.5e-05	0.000631	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BSG—melanoma	4.5e-05	0.000631	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CSPG4—melanoma	4.5e-05	0.000631	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—melanoma	4.5e-05	0.00063	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPAM—melanoma	4.36e-05	0.000611	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—melanoma	4.34e-05	0.000608	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—melanoma	4.3e-05	0.000603	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HDAC6—melanoma	4.3e-05	0.000602	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—melanoma	4.16e-05	0.000582	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.12e-05	0.000578	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NPPA—melanoma	4.07e-05	0.000571	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—melanoma	4.02e-05	0.000563	CbGpPWpGaD
Zoledronate—ABCC1—Disease—VCAN—melanoma	3.97e-05	0.000557	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—melanoma	3.95e-05	0.000554	CbGpPWpGaD
Zoledronate—ABCC1—Disease—WNT5A—melanoma	3.94e-05	0.000553	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—melanoma	3.93e-05	0.000551	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—melanoma	3.9e-05	0.000547	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—melanoma	3.8e-05	0.000532	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—melanoma	3.79e-05	0.000531	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLA2G6—melanoma	3.71e-05	0.000519	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PRKCA—melanoma	3.7e-05	0.000519	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ERCC2—melanoma	3.67e-05	0.000514	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—melanoma	3.66e-05	0.000513	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—melanoma	3.52e-05	0.000492	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—melanoma	3.46e-05	0.000484	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—melanoma	3.45e-05	0.000483	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—melanoma	3.42e-05	0.000479	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—melanoma	3.41e-05	0.000478	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CD—melanoma	3.33e-05	0.000467	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—VCAN—melanoma	3.33e-05	0.000466	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—melanoma	3.29e-05	0.000461	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GAB2—melanoma	3.17e-05	0.000444	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.15e-05	0.000441	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FASN—melanoma	3.1e-05	0.000434	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.04e-05	0.000426	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CB—melanoma	3.01e-05	0.000422	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—melanoma	2.99e-05	0.000418	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTEN—melanoma	2.98e-05	0.000417	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FOXO4—melanoma	2.98e-05	0.000417	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HDAC2—melanoma	2.98e-05	0.000417	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CXCR4—melanoma	2.98e-05	0.000417	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD44—melanoma	2.94e-05	0.000413	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CB—melanoma	2.91e-05	0.000407	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—melanoma	2.9e-05	0.000406	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—melanoma	2.88e-05	0.000403	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP17A1—melanoma	2.81e-05	0.000394	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—melanoma	2.8e-05	0.000392	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.77e-05	0.000388	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.73e-05	0.000383	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT3—melanoma	2.72e-05	0.000381	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNA11—melanoma	2.65e-05	0.000372	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTEN—melanoma	2.6e-05	0.000365	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	2.6e-05	0.000364	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FASN—melanoma	2.6e-05	0.000364	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A5—melanoma	2.55e-05	0.000358	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—melanoma	2.55e-05	0.000357	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—melanoma	2.52e-05	0.000352	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—melanoma	2.51e-05	0.000352	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNAQ—melanoma	2.47e-05	0.000345	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CD44—melanoma	2.47e-05	0.000345	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.41e-05	0.000338	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB4—melanoma	2.4e-05	0.000336	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.39e-05	0.000335	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN2B—melanoma	2.38e-05	0.000333	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1B1—melanoma	2.36e-05	0.000331	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD86—melanoma	2.3e-05	0.000322	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF1—melanoma	2.23e-05	0.000313	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—melanoma	2.22e-05	0.000311	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—melanoma	2.2e-05	0.000308	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFRA—melanoma	2.16e-05	0.000303	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCA—melanoma	2.14e-05	0.0003	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERCC2—melanoma	2.12e-05	0.000297	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—melanoma	2.1e-05	0.000294	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAP2K2—melanoma	2.09e-05	0.000293	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.09e-05	0.000292	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—melanoma	1.99e-05	0.000279	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HLA-A—melanoma	1.99e-05	0.000279	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RAC1—melanoma	1.98e-05	0.000278	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCB1—melanoma	1.95e-05	0.000273	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTEN—melanoma	1.92e-05	0.000269	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—melanoma	1.9e-05	0.000266	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—melanoma	1.84e-05	0.000257	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PRKCA—melanoma	1.79e-05	0.000251	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ERCC2—melanoma	1.78e-05	0.000249	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—melanoma	1.77e-05	0.000248	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS2—melanoma	1.73e-05	0.000242	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—melanoma	1.72e-05	0.000241	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOTCH1—melanoma	1.71e-05	0.00024	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD80—melanoma	1.68e-05	0.000235	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KIT—melanoma	1.68e-05	0.000235	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—melanoma	1.68e-05	0.000235	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGF—melanoma	1.66e-05	0.000232	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—melanoma	1.58e-05	0.000221	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—melanoma	1.5e-05	0.00021	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAP2K1—melanoma	1.48e-05	0.000208	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—melanoma	1.47e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.47e-05	0.000206	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—melanoma	1.45e-05	0.000203	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF2—melanoma	1.41e-05	0.000198	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—melanoma	1.4e-05	0.000197	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—melanoma	1.35e-05	0.00019	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—melanoma	1.35e-05	0.00019	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MDM2—melanoma	1.32e-05	0.000185	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—melanoma	1.3e-05	0.000182	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—melanoma	1.28e-05	0.00018	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD4—melanoma	1.28e-05	0.00018	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—melanoma	1.27e-05	0.000178	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—melanoma	1.23e-05	0.000173	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—melanoma	1.22e-05	0.000171	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—melanoma	1.2e-05	0.000169	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CTNNB1—melanoma	1.14e-05	0.000159	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—melanoma	1.11e-05	0.000156	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—melanoma	1.11e-05	0.000155	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—melanoma	1.11e-05	0.000155	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—melanoma	1.08e-05	0.000151	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—melanoma	1.07e-05	0.000149	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—melanoma	9.92e-06	0.000139	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NRAS—melanoma	9.9e-06	0.000139	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—melanoma	9.48e-06	0.000133	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—melanoma	9.29e-06	0.00013	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—melanoma	9.22e-06	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK1—melanoma	9.02e-06	0.000126	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—melanoma	9.02e-06	0.000126	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—melanoma	8.52e-06	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—melanoma	7.83e-06	0.00011	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—melanoma	7.24e-06	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—melanoma	6.93e-06	9.71e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—melanoma	6.56e-06	9.18e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—melanoma	6.39e-06	8.96e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—melanoma	5.36e-06	7.5e-05	CbGpPWpGaD
